Article contents
How are the sub-unit pertussis vaccines to be evaluated?
Published online by Cambridge University Press: 19 October 2009
Summary
Although an effective whooping cough vaccine has been available in the UK since the 1950s, its current association with neurotoxicity has resulted in poor uptake: as a consequence major epidemics (with significant morbidity and mortality) arc still being experienced.
Component (sub-unit) vaccines, which incorporate those antigens thought to be concerned with generating a protective effect, have been developed and are now available for field testing. This paper addresses how such a vaccine might be evaluated, the organization of a trial and the difficulties to be expected.
- Type
- Research Article
- Information
- Copyright
- Copyright © Cambridge University Press 1987
References
REFERENCES
- 3
- Cited by